BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15977648)

  • 1. Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA).
    Jellinger KA
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):554. PubMed ID: 15977648
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA).
    Mikolaenko I; Pletnikova O; Kawas CH; O'Brien R; Resnick SM; Crain B; Troncoso JC
    J Neuropathol Exp Neurol; 2005 Feb; 64(2):156-62. PubMed ID: 15751230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
    Krüger R; Müller T; Riess O
    J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
    Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
    Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of alpha-synucleinopathy and Lewy pathology. Alpha-synuclein expression in transgenic mice.
    Barbieri S; Hofele K; Wiederhold KH; Probst A; Mistl C; Danner S; Kauffmann S; Sommer B; Spooren W; Tolnay M; Bilbe G; van der Putten H
    Adv Exp Med Biol; 2001; 487():147-67. PubMed ID: 11403156
    [No Abstract]   [Full Text] [Related]  

  • 7. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.
    Campbell BC; Li QX; Culvenor JG; Jäkälä P; Cappai R; Beyreuther K; Masters CL; McLean CA
    Neurobiol Dis; 2000 Jun; 7(3):192-200. PubMed ID: 10860784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA).
    O'Brien RJ; Resnick SM; Zonderman AB; Ferrucci L; Crain BJ; Pletnikova O; Rudow G; Iacono D; Riudavets MA; Driscoll I; Price DL; Martin LJ; Troncoso JC
    J Alzheimers Dis; 2009; 18(3):665-75. PubMed ID: 19661626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases.
    Mukaetova-Ladinska EB; Hurt J; Jakes R; Xuereb J; Honer WG; Wischik CM
    J Neuropathol Exp Neurol; 2000 May; 59(5):408-17. PubMed ID: 10888371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases.
    Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ
    Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein, Parkinson's disease, and Alzheimer's disease.
    Kim S; Seo JH; Suh YH
    Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S9-13. PubMed ID: 15109581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
    Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
    Lotharius J; Brundin P
    Nat Rev Neurosci; 2002 Dec; 3(12):932-42. PubMed ID: 12461550
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.
    Parkkinen L; Soininen H; Alafuzoff I
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):363-7. PubMed ID: 12722828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease: alpha-synuclein and parkin in protein aggregation and the reversal of unfolded protein stress.
    Jakobsen LD; Jensen PH
    Methods Mol Biol; 2003; 232():57-66. PubMed ID: 12840539
    [No Abstract]   [Full Text] [Related]  

  • 18. [Synucleins--to have or not to have].
    Ninkina NN; Bukhman VL
    Genetika; 2000 Nov; 36(11):1487-91. PubMed ID: 11094765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein and presynaptic function: implications for Parkinson's disease.
    Lykkebo S; Jensen PH
    Neuromolecular Med; 2002; 2(2):115-29. PubMed ID: 12428807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein and Parkinson's disease.
    Golbe LI
    Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.